Literature DB >> 8627232

Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis.

S Amor1, M F Scallan, M M Morris, H Dyson, J K Fazakerley.   

Abstract

The course of Semliki Forest virus (SFV) A7(74) infection in immunocompetent BALB/c, athymic nu/nu and severe combined immunodeficient (SCID) mice was compared. BALB/c mice remained healthy and exhibited transient viraemia and infectious virus in the brain from days 2 to 7. Antibodies were detectable by day 5. In comparison, SCID mice displayed a high incidence of paralysis and died: the average day of death was day 23. From infection until death, virus was present in blood and brain. No antibodies were detectable. Athymic mice were intermediate with a transient viraemia and a persistent (> 210 days) sub-clinical central nervous system (CNS) infection. These mice produced anti-viral IgM but not IgG. The pattern of infection in BALB/c or nu/nu mice could be recreated in infected SCID mice by transfer of immune serum from BALB/c or nu/nu mice with the important exception that although BALB/c immune serum could abolish infectivity titres in the CNS, scattered cells positive for viral RNA remained. Transfer of serum decreased mortality and delayed the onset of paralysis. Transfer to infected SCID mice of a non-neutralizing IgG anti-E2 monoclonal antibody did not affect the viraemia but could also reduce brain virus titres. Irrespective of specific immune responses, virus replication in CNS cells was restricted, was generally non-cytopathic and in the absence of specific immune responses could persist. From day 14 lesions of inflammatory, primary demyelination were observed throughout the CNS of BALB/c mice. In contrast, despite prolonged brain virus titres, no demyelinating lesions were observed in infected nu/nu or SCID mice. Lesions could be initiated in the latter by transfer of spleen cells but not antibody. In summary, the focal restricted infection in the CNS of adult mice infected with SFV A7(74) is independent of specific immune responses. IgM antibodies clear the viraemia. IgG antibodies including non-neutralizing antibodies reduce and clear infectious virus but cells positive for viral RNA remain. These may normally be cleared by T cell responses which are damaging and give rise to lesions of demyelination.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627232     DOI: 10.1099/0022-1317-77-2-281

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  30 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  Replicase complex genes of Semliki Forest virus confer lethal neurovirulence.

Authors:  M T Tuittila; M G Santagati; M Röyttä; J A Määttä; A E Hinkkanen
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages.

Authors:  M L Linn; L Mateo; J Gardner; A Suhrbier
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  A single amino acid change in the nuclear localization sequence of the nsP2 protein affects the neurovirulence of Semliki Forest virus.

Authors:  John K Fazakerley; Amanda Boyd; Marja L Mikkola; Leevi Kääriäinen
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus.

Authors:  Markus J V Vähä-Koskela; Minna T Tuittila; Petra T Nygårdas; Jonas K-E Nyman; Markus U Ehrengruber; Martin Renggli; Ari E Hinkkanen
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

6.  Semliki Forest virus A7(74) transduces hippocampal neurons and glial cells in a temperature-dependent dual manner.

Authors:  Markus U Ehrengruber; Martin Renggli; Olivier Raineteau; Sonia Hennou; Markus J V Vähä-Koskela; Ari E Hinkkanen; Kenneth Lundstrom
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

7.  bcl-2 acts early to restrict Semliki Forest virus replication and delays virus-induced programmed cell death.

Authors:  M F Scallan; T E Allsopp; J K Fazakerley
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 8.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response.

Authors:  Gerald Barry; Lucy Breakwell; Rennos Fragkoudis; Ghassem Attarzadeh-Yazdi; Julio Rodriguez-Andres; Alain Kohl; John K Fazakerley
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

10.  Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice.

Authors:  Jari E Heikkilä; Markus J V Vähä-Koskela; Janne J Ruotsalainen; Miika W Martikainen; Marianne M Stanford; J Andrea McCart; John C Bell; Ari E Hinkkanen
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.